Parabilis Medicines, Inc. (PBLS)
Data as of , from SEC Form 4 filings.
See up to 3 months of PBLS. The 7-day demo opens the 1M and 3M ranges and puts PBLS on your watchlist.
Start 7-day demoLatest PBLS insider trades
About Parabilis Medicines, Inc. (PBLS)
The SEC lists Parabilis Medicines, Inc. under CIK 0001657677, in pharmaceutical preparations. It is grouped with Health Care companies on this site. Its offering priced on 10 June 2026 and it trades on NASDAQ.
PBLS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 6 | 244,593 | $6.92M |
| Grant or award | 1 | 20,294 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PBLS insider transactions (Form 4)
5517 Form 4 filings on record, the earliest from Jun 11, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Craig Tendler - Director | Grant or award | Stock Option (Right to Buy) | 20,294 | $0.00 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Voting Common Stock | 98,433 | $27.13 footnote F1 | $2.67M | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Voting Common Stock | 32,987 | $27.72 footnote F4 | $914K | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Voting Common Stock | 21,696 | $27.96 footnote F5 | $607K | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Voting Common Stock | 6,504 | $29.17 footnote F6 | $190K | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Voting Common Stock | 37,723 | $30.00 footnote F7 | $1.13M | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Voting Common Stock | 47,250 | $29.77 footnote F8 | $1.41M | |
| ||||||
| Guy Levy - 10% Owner | Open-market purchase | Common Stock, par value $0.0001 per share | 125,000 | $20.00 | $2.50M | |
| Guy Levy - 10% Owner | Other | Common Stock, par value $0.0001 per share | 527,070 | $9.48 | $5.00M | |
| Guy Levy - 10% Owner | Other | Series F Preferred Stock | 527,070 | $0.00 | - | |
| Guy Levy - 10% Owner | Open-market purchase | Common Stock, par value $0.0001 per share | 375,000 | $20.00 | $7.50M | |
| Alan Sebulsky | Open-market purchase | Common Stock | 8,435 | $27.67 footnote F1 | $233K | |
| Alan Sebulsky | Open-market purchase | Common Stock | 5,000 | $26.00 footnote F3 | $130K | |
| Alan Sebulsky | Open-market purchase | Common Stock | 4,065 | $27.10 footnote F4 | $110K | |
| ||||||
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Voting Common Stock | 19,728,353 | $20.00 | $394.57M | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Voting Common Stock | 1,460,397 | $20.00 | $29.21M | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Series E Preferred Stock | 642,250 | - footnote F1 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Series E Preferred Stock | 160,562 | - footnote F1 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Series F Preferred Stock | 9,445,363 | - footnote F2 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Series F Preferred Stock | 1,666,829 | - footnote F2 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Voting Common Stock | 6,556,740 | - footnote F1,F2 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Voting Common Stock | 1,187,881 | - footnote F1,F2 | - | |
| ||||||
| Edward M. Fitzgerald | Other | Common Stock | 5,271 | - footnote F3 | - | |
| Edward M. Fitzgerald | Other | Series B Preferred Stock | 5,332 | - footnote F1 | - | |
| Edward M. Fitzgerald | Other | Series C Preferred Stock | 3,666 | - footnote F2 | - | |
| Edward M. Fitzgerald | Other | Series F Preferred Stock | 8,111 | - footnote F3 | - | |
| Edward M. Fitzgerald | Other | Common Stock | 5,539 | - footnote F1 | - | |
| Edward M. Fitzgerald | Other | Common Stock | 3,878 | - footnote F2 | - | |
| ||||||
| Alan Sebulsky | Open-market purchase | Common Stock | 12,500 | $20.00 | $250K | |
| Alexis Borisy | Other | Series F Preferred Stock | 162,221 | - footnote F1 | - | |
| Alexis Borisy | Other | Common Stock | 105,414 | - footnote F1 | - | |
| ||||||
| James E. Flynn - 10% Owner | Other | Voting Common Stock | 149,238 | - footnote F2 | - | |
| James E. Flynn - 10% Owner | Other | Voting Common Stock | 149,238 | - footnote F2 | - | |
| James E. Flynn - 10% Owner | Other | Voting Common Stock | 260,992 | - footnote F3 | - | |
| James E. Flynn - 10% Owner | Other | Voting Common Stock | 260,992 | - footnote F3 | - | |
| James E. Flynn - 10% Owner | Other | Voting Common Stock | 407,132 | - footnote F4 | - | |
| James E. Flynn - 10% Owner | Other | Voting Common Stock | 407,132 | - footnote F4 | - | |
| James E. Flynn - 10% Owner | Other | Series A Preferred Stock | 166,070 | - footnote F1 | - | |
| James E. Flynn - 10% Owner | Other | Series A Preferred Stock | 166,070 | - footnote F1 | - | |
| James E. Flynn - 10% Owner | Other | Series B Preferred Stock | 143,650 | - footnote F2 | - | |
| James E. Flynn - 10% Owner | Other | Series B Preferred Stock | 143,650 | - footnote F2 | - | |
| James E. Flynn - 10% Owner | Other | Series C Preferred Stock | 246,732 | - footnote F3 | - | |
| James E. Flynn - 10% Owner | Other | Series C Preferred Stock | 246,732 | - footnote F3 | - | |
| James E. Flynn - 10% Owner | Other | Series D Preferred Stock | 464,550 | - footnote F4 | - | |
| James E. Flynn - 10% Owner | Other | Series D Preferred Stock | 464,550 | - footnote F4 | - | |
| James E. Flynn - 10% Owner | Other | Voting Common Stock | 122,990 | - footnote F1 | - | |
| James E. Flynn - 10% Owner | Other | Voting Common Stock | 122,990 | - footnote F1 | - | |
| ||||||
| RA CAPITAL MANAGEMENT, L.P. | Grant or award | Stock Option (Right to Buy) | 20,215 | $0.00 | - | |
| Alexis Borisy | Grant or award | Stock Option (Right to Buy) | 20,215 | $0.00 | - | |
| Barbara Weber | Grant or award | Stock Option (Right to Buy) | 20,215 | $0.00 | - | |
| Krishna Yeshwant | Grant or award | Stock Option (Right to Buy) | 20,215 | $0.00 | - | |
| Edward M. Fitzgerald | Grant or award | Stock Option (Right to Buy) | 20,215 | $0.00 | - | |
| Grant or award | Stock Option (Right to Buy) | 20,215 | $0.00 | - | ||
| Richard Klausner | Grant or award | Stock Option (Right to Buy) | 20,215 | $0.00 | - | |
| Alan Sebulsky | Grant or award | Stock Option (Right to Buy) | 39,792 | $0.00 | - | |
PBLS insider trading FAQ
What is the latest insider trade for PBLS?
Parabilis Medicines, Inc. (PBLS) had 2 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for PBLS runs to 17 Form 4 filings, the earliest from 2026-06-11. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PBLS stock?
6 insider purchases of PBLS were filed in the last 90 days, totaling $6.92M.
How many insiders are selling PBLS stock?
No insider sales of PBLS were filed in the last 90 days.
Where can I see PBLS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PBLS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Craig Tendler view on EDGAR
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Guy Levy view on EDGAR
- - Alan Sebulsky view on EDGAR
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Edward M. Fitzgerald view on EDGAR
- - Alan Sebulsky view on EDGAR
- - Alexis Borisy view on EDGAR
- - James E. Flynn view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where PBLS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PBLS with a 7-day demo
- PBLS on your watchlist
- Every PBLS Form 4 filing on record
- Up to 3 months of PBLS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive